Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced that over the next three weeks, it will provide corporate presentations at several investor conferences and host a conference call and webcast to review data presented at the European Hematology Association’s annual meeting.
Help employers find you! Check out all the jobs and post your resume.
